Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Speakers’ Corner 3: Vascular Disease I Session

Date/Time: | Room:

Back to Previous

Title

Theme

10:15:00 H. Clarke United Kingdom Functional and structural characteristics in patients with diabetic macular oedema after switching from Ranibizumab to Aflibercept treatment. One year results in real world settings.
10:20:00 C. Egan United Kingdom Feasibility study for the introduction of automated retinal image analysis software into routine high volume diabetic retinopathy screening in the United Kingdom.
10:25:00 M. Niestrata-Ortiz United Kingdom Thickening of the choroid in children with type 1 diabetes mellitus and no diabetic retinopathy
10:30:00 S. Dundar Turkey Retinal nerve fiber layer thickness in diabetic patients
10:35:00 M. Teo United Kingdom Real world data of 20,066 cataract operations – Incidence of post-operative macular oedema in diabetic patients with or without diabetic retinopathy.
10:40:00 V. Felcida United Kingdom Fluocinolone acetonide intravitreal implant (Iluvien) as the treatment for chronic macular oedema (MO) in Retinal vein occlusions (RVO): case-series of one year result
10:45:00 A. Maalej Tunisia The effects of hyperbaric oxygen therapy on diabetic retinopathy
10:50:00 C. Wright United Kingdom Nutrition matters in diabetic macular edema (DME) – or does it? A clinical analysis of the evidence supporting the use of food interventions in a combined approach to treating DME
10:55:00 V. Castro-Navarro Spain Outcomes in different subtypes of diabetic macular edema treated with ozurdex: anatomical and functional results in cystoid macular edema
11:00:00 A. Dale United Kingdom Diabetic retinopathy and maculopathy levels in an English county
11:05:00 I. Damian Romania Intravitreal Bevacizumab as an adjunct to vitrectomy for vitreous hemorrhage in patients with proliferative diabetic retinopathy
11:10:00 G. Spital Germany DIVERSE: Non-inferiority of ranibizumab administered at the discretion of the investigator to standard care (pro re nata administration) in diabetic macula edema: A 12-month, randomized, controlled, VA-assessor blinded, multicenter, phase IV trial
11:15:00 Y. Sugiura Japan Relationship between metamorphopsia and inner retinal structure following intravitreal ranibizumab injection for branch retinal vein occlusion
11:20:00 C. Arruabarrena Spain OCT in diabetic telemedicine screening
11:25:00 V. Matuskova Czech Republic Limiting factors of improvement of visual acuity after half-fluence photodynamic therapy in patients with chronic central serous chorioretinopathy
11:30:00 C. Papandreou United Kingdom What is the efficacy of oral sucrose and non-nutritive sucking on pain response in retinopathy of prematurity screening examinations.

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved